Inhaltsbereich
| 294 Einträge | « ‹ 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15 › » |
Seite 12 / 15
 Druckansicht
|
| St. Gallen/Vienna 2019: A Brief Summary of the Consensus Discussion on the Optimal Primary Breast Cancer Treatment. |
| Balic M, Thomssen C, Würstlein R, Gnant M, Harbeck N |
| Breast care (Basel, Switzerland). 2019 Apr 4. doi: 10.1159/000499931. pii: brc-0014-0103. pmc: PMC6886108 |
| PMID: 31798382 |
| Efficacy and Safety of Tailored and Dose-Dense Adjuvant Chemotherapy and Trastuzumab for Resected HER2-Positive Breast Cancer: Results From the Phase 3 PANTHER Trial. |
| Papakonstantinou A, Matikas A, Bengtsson NO, Malmström P, Hedayati E, Steger G, Untch M, Hübbert L, Johansson H, Hellström M, Gnant M, Loibl S, Greil R, Moebus V, Foukakis T, Bergh J |
| Cancer. 2019 Dec 18. doi: 10.1002/cncr.32653 |
| PMID: 31851385 |
| The Prognostic Index Independently Predicts Survival in Patients with Pancreatic Ductal Adenocarcinoma Undergoing Resection. |
| Gruber ES, Jomrich G, Kaider A, Gnant M, Sahora K, Schindl M |
| Annals of surgical oncology. 2020 Jan 3. doi: 10.1245/s10434-019-08161-6. pii: 10.1245/s10434-019-08161-6 |
| PMID: 31900809 |
| Endocrine therapy with or without whole breast irradiation in low-risk breast cancer patients after breast-conserving surgery: 10-year results of the Austrian Breast and Colorectal Cancer Study Group 8A trial. |
| Fastner G, Sedlmayer F, Widder J, Metz M, Geinitz H, Kapp K, Fesl C, Sölkner L, Greil R, Jakesz R, Kwasny W, Heck D, Bjelic-Radisic V, Balic M, Stöger H, Wieder U, Zwrtek R, Semmler D, Horvath W, Melbinger-Zeinitzer E, Wiesholzer M, Wette V, Gnant M |
| European journal of cancer (Oxford, England : 1990). 2020 Jan 18. pii: S0959-8049(19)30873-1. doi: 10.1016/j.ejca.2019.11.024 |
| PMID: 31962198 |
| Estimating the benefits of therapy for early-stage breast cancer: the St. Gallen International Consensus Guidelines for the primary therapy of early breast cancer 2019. |
| Burstein HJ, Curigliano G, Loibl S, Dubsky P, Gnant M, Poortmans P, Colleoni M, Denkert C, Piccart-Gebhart M, Regan M, Senn HJ, Winer EP, Thurlimann B |
| Annals of oncology : official journal of the European Society for Medical Oncology. 2019 Dec 27. pii: S0923-7534(19)60978-6. doi: 10.1093/annonc/mdz235 |
| PMID: 31987446 |
| Effects of neratinib on health-related quality of life in women with HER2-positive early-stage breast cancer: longitudinal analyses from the randomized phase III ExteNET trial. |
| Delaloge S, Cella D, Ye Y, Buyse M, Chan A, Barrios CH, Holmes FA, Mansi J, Iwata H, Ejlertsen B, Moy B, Chia SKL, Gnant M, Smichkoska S, Ciceniene A, Martinez N, Filipović S, Ben-Baruch NE, Joy AA, Langkjer ST, Senecal F, de Boer RH, Moran S, Yao B, Bryce R, Auerbach A, Fallowfield L, Martin M |
| Annals of oncology : official journal of the European Society for Medical Oncology. 2019 Dec 4. pii: S0923-7534(19)31112-3. doi: 10.1093/annonc/mdz016 |
| PMID: 31987273 |
| The impact of menopause on bone, zoledronic acid, and implications for breast cancer growth and metastasis. |
| Hadji P, Coleman R, Gnant M, Green J |
| Annals of oncology : official journal of the European Society for Medical Oncology. 2019 Dec 4. pii: S0923-7534(19)37530-1. doi: 10.1093/annonc/mds169 |
| PMID: 32018729 |
| Efficacy and safety of everolimus plus exemestane in patients with HR+, HER2- advanced breast cancer progressing on/after prior endocrine therapy in routine clinical practice: Primary results from the non-interventional study, STEPAUT. |
| Steger GG, Egle D, Bartsch R, Pfeiler G, Petru E, Greil R, Helfgott R, Marth C, Öhler L, Hubalek M, Lang A, Tinchon C, Haslbauer F, Redl A, Hock K, Hennebelle M, Mraz B, Gnant M |
| Breast (Edinburgh, Scotland). 2020 Jan 31. pii: S0960-9776(20)30036-9. doi: 10.1016/j.breast.2020.01.035 |
| PMID: 32062536 |
| Prognostic value of endopredict for invasive lobular carcinomas in the combined ABCSG-6/8 and TransATAC trials. |
| Sestak I, Filipits M, Buus R, Rudas M, Knauer M, Kronenwett R, Cuzick J, Gnant MI, Dowsett M, Dubsky P |
| Annals of oncology : official journal of the European Society for Medical Oncology. 2020 Jan 8. pii: S0923-7534(19)30274-1. doi: 10.1093/annonc/mdz095.001 |
| PMID: 32084704 |
| mRNA expression of ER, PR, HER2 and Ki67 are concordant to central ihc and predict clinical outcome: A validation study from the ABCSG-6 biomarker cohort. |
| Filipits M, Rudas M, Singer C, Bago-Horvath Z, Greil R, Balic M, Lax SF, Wu N, Zhao S, Weidler J, Bates M, Hlauschek D, Gnant M, Dubsky P |
| Annals of oncology : official journal of the European Society for Medical Oncology. pii: S0923-7534(19)49954-7. doi: 10.1093/annonc/mdy294.003 |
| PMID: 32137237 |
| Androgen receptor expression in breast cancer brain metastases. |
| Bergen ES, Berghoff ASS, Rajky U, Rudas M, Bago-Horvath Z, Exner R, Dieckmann K, Widhalm G, Gnant MI, Zielinski CC, Steger GG, Preusser M, Bartsch R |
| Annals of oncology : official journal of the European Society for Medical Oncology. pii: S0923-7534(19)48796-6. doi: 10.1093/annonc/mdy273.367 |
| PMID: 32136166 |
| Long-term (up to 16 months) health-related quality of life after adjuvant tailored dose-dense chemotherapy vs. standard three-weekly chemotherapy in women with high-risk early breast cancer. |
| Brandberg Y, Johansson H, Hellström M, Gnant M, Möbus V, Greil R, Foukakis T, Bergh J |
| Breast cancer research and treatment. 2020 Mar 31. doi: 10.1007/s10549-020-05602-9. pii: 10.1007/s10549-020-05602-9 |
| PMID: 32232698 |
| Efficacy and safety of the therapeutic cancer vaccine tecemotide (L-BLP25) in early breast cancer: Results from a prospective, randomised, neoadjuvant phase II study (ABCSG 34). |
| Singer CF, Pfeiler G, Hubalek M, Bartsch R, Stöger H, Pichler A, Petru E, Bjelic-Radisic V, Greil R, Rudas M, Maria Tea MK, Wette V, Petzer AL, Sevelda P, Egle D, Dubsky PC, Filipits M, Fitzal F, Exner R, Jakesz R, Balic M, Tinchon C, Bago-Horvath Z, Frantal S, Gnant M |
| European journal of cancer (Oxford, England : 1990). 2020 Apr 20. pii: S0959-8049(20)30159-3. doi: 10.1016/j.ejca.2020.03.018 |
| PMID: 32325419 |
| Incidence and time course of everolimus-related adverse events in postmenopausal women with hormone receptor-positive advanced breast cancer: insights from BOLERO-2. |
| Rugo HS, Pritchard KI, Gnant M, Noguchi S, Piccart M, Hortobagyi G, Baselga J, Perez A, Geberth M, Csoszi T, Chouinard E, Srimuninnimit V, Puttawibul P, Eakle J, Feng W, Bauly H, El-Hashimy M, Taran T, Burris HA |
| Annals of oncology : official journal of the European Society for Medical Oncology. 2014 Mar 10. pii: S0923-7534(19)36498-1. doi: 10.1093/annonc/mdu009. pmc: PMC3969554 |
| PMID: 24615500 |
| Present and future breast cancer management--bench to bedside and back: a positioning paper of academia, regulatory authorities and pharmaceutical industry. |
| Bartsch R, Frings S, Marty M, Awada A, Berghoff AS, Conte P, Dickin S, Enzmann H, Gnant M, Hasmann M, Hendriks HR, Llombart A, Massacesi C, von Minckwitz G, Penault-Llorca F, Scaltriti M, Yarden Y, Zwierzina H, Zielinski CC |
| Annals of oncology : official journal of the European Society for Medical Oncology. 2013 Dec 18. pii: S0923-7534(19)36495-6. doi: 10.1093/annonc/mdt531 |
| PMID: 24351401 |
| Primary surgery versus no surgery in synchronous metastatic breast cancer: patient-reported quality-of-life outcomes of the prospective randomized multicenter ABCSG-28 Posytive Trial. |
| Bjelic-Radisic V, Fitzal F, Knauer M, Steger G, Egle D, Greil R, Schrenk P, Balic M, Singer C, Exner R, Soelkner L, Gnant M |
| BMC cancer. 2020 May 6. doi: 10.1186/s12885-020-06894-2. pii: 10.1186/s12885-020-06894-2 |
| PMID: 32375735 |
| ESMO Management and treatment adapted recommendations in the COVID-19 era: Breast Cancer. |
| de Azambuja E, Trapani D, Loibl S, Delaloge S, Senkus E, Criscitiello C, Poortman P, Gnant M, Di Cosimo S, Cortes J, Cardoso F, Paluch-Shimon S, Curigliano G |
| ESMO open. pii: esmoopen-2020-000793. doi: 10.1136/esmoopen-2020-000793 |
| PMID: 32439716 |
| IDO1 Paneth cells promote immune escape of colorectal cancer. |
| Pflügler S, Svinka J, Scharf I, Crncec I, Filipits M, Charoentong P, Tschurtschenthaler M, Kenner L, Awad M, Stift J, Schernthanner M, Bischl R, Herndler-Brandstetter D, Glitzner E, Moll HP, Casanova E, Timelthaler G, Sibilia M, Gnant M, Lax S, Thaler J, Müller M, Strobl B, Mohr T, Kaser A, Trajanoski Z, Heller G, Eferl R |
| Communications biology. 2020 May 22. doi: 10.1038/s42003-020-0989-y. pii: 10.1038/s42003-020-0989-y |
| PMID: 32444775 |
| The EndoPredict score predicts response to neoadjuvant chemotherapy and neoendocrine therapy in hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer patients from the ABCSG-34 trial. |
| Dubsky PC, Singer CF, Egle D, Wette V, Petru E, Balic M, Pichler A, Greil R, Petzer AL, Bago-Horvath Z, Fesl C, Meek SM, Kronenwett R, Rudas M, Gnant M, Filipits M |
| European journal of cancer (Oxford, England : 1990). 2020 Jun 2. pii: S0959-8049(20)30223-9. doi: 10.1016/j.ejca.2020.04.020 |
| PMID: 32502940 |
| Predictive value of molecular subtypes in premenopausal women with hormone receptor-positive early breast cancer: Results from the ABCSG Trial 5. |
| Bago-Horvath Z, Rudas M, Singer CF, Greil R, Balic M, Lax S, Kwasny W, Hulla W, Gnant M, Filipits M |
| Clinical cancer research : an official journal of the American Association for Cancer Research. 2020 Jun 16. pii: 1078-0432.CCR-20-0673. doi: 10.1158/1078-0432.CCR-20-0673 |
| PMID: 32546648 |
| 294 Einträge | « ‹ 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15 › » |
Seite 12 / 15
Druckansicht
|
Schnellinfo
-- Initiative Krebsforschung / Krebsforschungslauf
-- Cancer Care
-- Kliniken und Partner
-- CCC Cancer School
-- Young CCC
-- CCC Tumorboards
-- CCC Forschungscluster
-- CCC Units
-- CCC Platforms
-- SOPs / Leitlinien
-- Kontakt
-- Cancer Care
-- Kliniken und Partner
-- CCC Cancer School
-- Young CCC
-- CCC Tumorboards
-- CCC Forschungscluster
-- CCC Units
-- CCC Platforms
-- SOPs / Leitlinien
-- Kontakt
Featured
